US 8349879
Tricyclic compound and pharmaceutical use thereof
granted A61KA61K31/423A61K31/428
Quick answer
US patent 8349879 (Tricyclic compound and pharmaceutical use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/423, A61K31/428, A61P, A61P25/00